Scholarlink

<p>Interleukin (IL)-10, a prominent anti-inflammatory cytokine predominantly secreted by various immune cells, plays a crucial role in the pathophysiological mechanisms of inflammatory bowel disease (IBD). Mice deficient in IL-10 (IL-10<sup>−/−</sup>) progressively develop features of idiopathic enterocolitis as they mature. To advance our understanding of the molecular mechanisms underpinning chronic enterocolitis in IL-10<sup>−/−</sup> mice, we performed an extensive analysis of the transcriptome and proteome of colonic tissue from these mice manifesting colitis. The study employed bulk RNA sequencing (RNA-seq) and four-dimensional (4D) label-free mass spectrometry (MS) to facilitate an integrated analysis of the resultant omics data. Following an extensive series of quality control evaluations, 635 genes and 1,071 proteins were identified as differentially expressed. The principal aim of this integrated analysis was to elucidate novel signaling pathways and identify potential therapeutic targets for IBD treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrated transcriptomic and proteomic profiling of colonic tissue in interleukin-10-deficient mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Lili Li,
  • Chunxiang Ma,
  • Kexin Chen,
  • Yongbin Jia,
  • Yushan Wu,
  • Hao Lin,
  • Rui Cheng,
  • Mingshan Jiang,
  • Zhen Zeng,
  • Jingjing Chen,
  • Jiangmei Pang,
  • Jiaxin Li,
  • Hu Zhang

摘要

Interleukin (IL)-10, a prominent anti-inflammatory cytokine predominantly secreted by various immune cells, plays a crucial role in the pathophysiological mechanisms of inflammatory bowel disease (IBD). Mice deficient in IL-10 (IL-10−/−) progressively develop features of idiopathic enterocolitis as they mature. To advance our understanding of the molecular mechanisms underpinning chronic enterocolitis in IL-10−/− mice, we performed an extensive analysis of the transcriptome and proteome of colonic tissue from these mice manifesting colitis. The study employed bulk RNA sequencing (RNA-seq) and four-dimensional (4D) label-free mass spectrometry (MS) to facilitate an integrated analysis of the resultant omics data. Following an extensive series of quality control evaluations, 635 genes and 1,071 proteins were identified as differentially expressed. The principal aim of this integrated analysis was to elucidate novel signaling pathways and identify potential therapeutic targets for IBD treatment.